IBT Staff Reporter

11581-11610 (out of 154954)

Gilead Earnings Beat Street Estimates, Writedown Taken On Cancer Drug

Gilead Sciences Inc on Thursday said its first-quarter revenue rose 3%, helped by sales of HIV drug Biktarvy and COVID antiviral Veklury, but the company reported a net loss as it wrote down the value of its 2020 acquisition of Immunomedics following recent trial results for cancer drug Trodelvy.

Ukraine Accuses Russia Of Stealing Grain During War

Ukraine accused Russia on Thursday of stealing grain in territory it has occupied, an act which it said increased the threat to global food security posed by disruptions to spring sowing and the blocking of Ukrainian ports during the war.

Pages